28 July 2016

Sinclair IS Pharma cuts loss 

Robert Tyerman

Recently-merged Sinclair IS Pharma (SPH.L) has cut annual losses 31 per cent to £11.7 million and launched an Asia-Pacific marketing drive. The AIM-quoted company, which specialises in oral health, dermatology and wound care, increased turnover 19 per cent to nearly £33 million in the year to June.

Steered by entrepreneurial chief executive Chris Spooner, Sinclair, whose losses before exceptional items rose 14.5 per cent to £5.8 million, achieved several product launches last year. The company introduced its Autopiclair eczema and dermatitis cream into France, a market which returned to growth last year with a 21 per cent turnover gain to £12.5 million, and took its Kelo-cote scar reduction formulation into several European markets.

Outgoing chairman John Gregory says the merger of Sinclair Pharma with IS Pharma should lead to annual cost savings of £1 million and has already started to pay off more positively, as with a marketing agreement for the company's Episil treatment for oral mucositis pain. Grahame Cook, already a Sinclair director, will now chair the company, which has already launched two dermatology products in seven Asia-Pacific countries under its partnership with Singapore-based Invida Holdings, a leader in commercialising bio-pharmaceutical and healthcare products in the region.

Sinclair, which ended the financial year with £5 million cash, now has a 'bio-film busting' mouthwash for sale in the USA under the PerioShield banner through an agreement with Sunstar Americas and has several new products in the pipeline. Highlighted by Growth Company Investor at 28p last autumn, Sinclair shares have eased to 24p, valuing the company at £93.3 million, but could still outperform some sector peers over the medium term.

Tags: AIM market, Asia-Pacifuyc, Autopiclair, Chris Spooner, Dermatology, Wound care

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Synectics on the road to recovery

Synectics (AIM: SNX), the surveillance systems specialist, is on the road to recovery. The shares were hit badly by the downturn in the oil and gas industry which historically has been a key customer. Happily the slack is now being taken up elsewhere, with the order book up 34 per cent from the start of the year.

Profit from playing by the rules

One ‘industry’ that has boomed over recent decades is compliance. Everything has become a lot stricter as far as rules and regulations are concerned. It’s not enough to abide by the processes of our workplaces, we also need to demonstrate that proper procedures are in place and are being complied with. That’s good news for Ideagen (AIM: IDEA) whose software helps over 2,000 companies in regulated industries manage their governance, risk and compliance.

Collagen targets a step up in scale

Collagen Solutions (AIM: COS) results gave new CEO Jamal Rushdy an opportunity to set out his strategy for the company. Collagen has an unusually broad geographic footprint for a company of its £13 million size. The plan is to use this platform to exploit Collagen’s expertise in tissue engineering, both through contract manufacturing and developing its own medical devices.

Concepta Diagnostics reverses into Frontier shell

Cash shell Frontier Resources (AIM: FRI) has announced the reverse takeover of Concepta Diagnostics. Concepta is focused on women’s fertility and plans to have its first product in the market shortly.

Beam me up

Satellite Solutions Worldwide (AIM: SAT) has just pulled off a significant acquisition which increases its user base by 40 per cent. Avonline is a major UK competitor in satellite broadband and is being acquired for £10 million, funded by a further financing agreement with the Business Growth Fund.

Plastics looking to expand

Specialist manufacturer Plastics Capital has released an encouraging set of results and is looking to move into expansion mode. With 45 per cent of sales exported from the UK, the recent devaluation of sterling will be a help. Management also feels that the business is now on a stable footing after encountering tough conditions in the resources sector and emerging markets during recent periods.

More News